Future burden of MASLD in the United States: A state-level forecasting study, 2022-2050
{{output}}
Background and aim: The rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) poses a significant public health challenge, yet the future burden at a subnational level is poorly quantified. State-s... ...
